MPG.eBooks - Description: Off-Label use of intravenous immunoglobulin for autoimmune or inflammatory conditions: a review of clinical effectiveness

Cover Image

Read Now

Off-Label use of intravenous immunoglobulin for autoimmune or inflammatory conditions: a review of clinical effectiveness

This review aims to evaluate the clinical effectiveness of intravenous immunoglobulin (IVIG) in autoimmune or inflammatory conditions for which there is no Health Canada approval for the use of IVIG.

Bibliographic Details
Main Authors:	Peprah, Kwakye, Adcock, Lorna (Author)
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa CADTH April 6, 2018, 2018
Edition:	Version: 1.0
Series:	CADTH rapid response report: summary with critical appraisal
Subjects:	Autoimmune Diseases / Drug Therapy Off-label Use Treatment Outcome Immunoglobulins, Intravenous / Therapeutic Use
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK531791
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	This review aims to evaluate the clinical effectiveness of intravenous immunoglobulin (IVIG) in autoimmune or inflammatory conditions for which there is no Health Canada approval for the use of IVIG.
Physical Description:	1 PDF file (40 pages) illustration